Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Hugger Jakobsen

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|May 21, 2008
[Breast cancer in 32-year-old male]Ulla Schierup Nielsen, Erik Hugger Jakobsen
Ugeskrift for Laeger|March 27, 2024
Tobias Berg, Ann Søegaard Knop, Erik Hugger Jakobsen
Translational Oncology|December 16, 2014
New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast CancerPeer Horn, Erik Hugger Jakobsen, Jonna Skov Madsen, et al.
Molecular and Clinical Oncology|May 29, 2018
Bone loss during neoadjuvant/adjuvant chemotherapy for early stage breast cancer: A retrospective cohort studyChristian Tang Axelsen, Anders Bonde Jensen, Erik Hugger Jakobsen, et al.
Clinical Chemistry and Laboratory Medicine|February 20, 2013
Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancerEva Rabing Brix Petersen, Patricia Diana Sørensen, Erik Hugger Jakobsen, et al.
BMC Cancer|June 15, 2019
Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I geneIben Kümler, Eva Balslev, Jan Stenvang, et al.
Journal of Circulating Biomarkers|September 23, 2017
Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene AmplificationPatricia Diana Sørensen, Rikke Fredslund Andersen, Niels Pallisgaard, et al.
Breast Cancer Research and Treatment|January 25, 2012
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancerElse Maae, Dorte Aalund Olsen, Karina Dahl Steffensen, et al.
Anticancer Research|September 21, 2012
Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancerElse Maae, Rikke Fredslund Andersen, Karina Dahl Steffensen, et al.
Scientific Reports|April 23, 2020
Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control studyIna Mathilde Kjær, Dorte Aalund Olsen, Ivan Brandslund, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|May 21, 2008
[Breast cancer in 32-year-old male]Ulla Schierup Nielsen, Erik Hugger Jakobsen
Ugeskrift for Laeger|March 27, 2024
Tobias Berg, Ann Søegaard Knop, Erik Hugger Jakobsen
Translational Oncology|December 16, 2014
New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast CancerPeer Horn, Erik Hugger Jakobsen, Jonna Skov Madsen, et al.
Molecular and Clinical Oncology|May 29, 2018
Bone loss during neoadjuvant/adjuvant chemotherapy for early stage breast cancer: A retrospective cohort studyChristian Tang Axelsen, Anders Bonde Jensen, Erik Hugger Jakobsen, et al.
Clinical Chemistry and Laboratory Medicine|February 20, 2013
Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancerEva Rabing Brix Petersen, Patricia Diana Sørensen, Erik Hugger Jakobsen, et al.
BMC Cancer|June 15, 2019
Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I geneIben Kümler, Eva Balslev, Jan Stenvang, et al.
Journal of Circulating Biomarkers|September 23, 2017
Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene AmplificationPatricia Diana Sørensen, Rikke Fredslund Andersen, Niels Pallisgaard, et al.
Breast Cancer Research and Treatment|January 25, 2012
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancerElse Maae, Dorte Aalund Olsen, Karina Dahl Steffensen, et al.
Anticancer Research|September 21, 2012
Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancerElse Maae, Rikke Fredslund Andersen, Karina Dahl Steffensen, et al.
Scientific Reports|April 23, 2020
Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control studyIna Mathilde Kjær, Dorte Aalund Olsen, Ivan Brandslund, et al.
Pageof 3